Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in Patients With Benign Prostatic Hyperplasia

PURPOSE: To assess changes in lower urinary tract symptoms (LUTS), prostate volume, and serum prostate-specific antigen (PSA) after discontinuation of 5-alpha reductase inhibitor (5ARI) combination therapy in patients with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: From December 2003...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Won, Jung, Jae Hung, Kang, Tae Wook, Song, Jae Mann, Chung, Hyun Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897631/
https://www.ncbi.nlm.nih.gov/pubmed/24466398
http://dx.doi.org/10.4111/kju.2014.55.1.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897631/
https://www.ncbi.nlm.nih.gov/pubmed/24466398
http://dx.doi.org/10.4111/kju.2014.55.1.52

Ejemplares similares